NYSE:HCP - HCP Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $30.84 +0.27 (+0.88 %) (As of 02/18/2019 03:15 PM ET)Previous Close$30.5732Today's Range$30.76 - $30.9952-Week Range$21.48 - $31.88Volume4.04 million shsAverage Volume3.08 million shsMarket Capitalization$14.66 billionP/E Ratio16.95Dividend Yield4.78%Beta0.46 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email HCP, Inc. is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index. Receive HCP News and Ratings via Email Sign-up to receive the latest news and ratings for HCP and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Real estate investment trusts Sub-IndustrySpecialized REITs SectorFinance Current SymbolNYSE:HCP Previous Symbol CUSIP40414L10 Webwww.hcpi.com Phone949-407-0700Debt Debt-to-Equity Ratio1.21 Current Ratio0.48 Quick Ratio0.48Price-To-Earnings Trailing P/E Ratio16.95 Forward P/E Ratio17.52 P/E Growth13.66 Sales & Book Value Annual Sales$1.85 billion Price / Sales7.94 Cash Flow$2.0880 per share Price / Cash Flow14.77 Book Value$11.93 per share Price / Book2.59Profitability EPS (Most Recent Fiscal Year)$1.82 Net Income$414.16 million Net Margins57.41% Return on Equity19.23% Return on Assets7.83%Miscellaneous Employees190 Outstanding Shares475,485,000Market Cap$14.66 billion OptionableOptionable HCP (NYSE:HCP) Frequently Asked Questions What is HCP's stock symbol? HCP trades on the New York Stock Exchange (NYSE) under the ticker symbol "HCP." How often does HCP pay dividends? What is the dividend yield for HCP? HCP announced a quarterly dividend on Thursday, January 31st. Investors of record on Tuesday, February 19th will be given a dividend of $0.37 per share on Thursday, February 28th. This represents a $1.48 annualized dividend and a yield of 4.80%. The ex-dividend date of this dividend is Friday, February 15th. View HCP's Dividend History. How were HCP's earnings last quarter? HCP, Inc. (NYSE:HCP) posted its quarterly earnings data on Wednesday, February, 13th. The real estate investment trust reported $1.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $1.30. The real estate investment trust had revenue of $441.92 million for the quarter, compared to analyst estimates of $445.81 million. HCP had a return on equity of 19.23% and a net margin of 57.41%. HCP's revenue for the quarter was down .3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.48 EPS. View HCP's Earnings History. When is HCP's next earnings date? HCP is scheduled to release their next quarterly earnings announcement on Thursday, May 2nd 2019. View Earnings Estimates for HCP. What guidance has HCP issued on next quarter's earnings? HCP updated its FY19 earnings guidance on Wednesday, February, 13th. The company provided earnings per share (EPS) guidance of $1.70-1.76 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.76. What price target have analysts set for HCP? 15 analysts have issued 1-year price objectives for HCP's shares. Their predictions range from $21.00 to $33.00. On average, they expect HCP's share price to reach $27.50 in the next year. This suggests that the stock has a possible downside of 10.8%. View Analyst Price Targets for HCP. What is the consensus analysts' recommendation for HCP? 15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HCP in the last year. There are currently 2 sell ratings, 5 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for HCP. What are Wall Street analysts saying about HCP stock? Here are some recent quotes from research analysts about HCP stock: 1. According to Zacks Investment Research, "HCP third-quarter 2018 funds from operations (FFO) as adjusted of 44 cents surpassed the Zacks Consensus Estimate. However, the bottom line fell short of the prior-year tally of 48 cents. Further, revenues missed the Zacks Consensus Estimate. Notably, a 6.3% decrease in senior-housing operating portfolio cash net operating income (NOI) marred results. The company has undertaken portfolio-repositioning measures by selling assets in its portfolio. Although such efforts are a strategic fit for the long term, the dilutive impact on earnings in the near term from these dispositions are unavoidable. Further, softness in the seniors housing market fundamentals amid new supply is anticipated to thwart the company’s pricing power. Although shares of HCP have outperformed the industry it belongs to over the past year, the stock has limited upside potential given lack of positive estimate revisions." (11/13/2018) 2. Cantor Fitzgerald analysts commented, "We are initiating coverage of HCP with a $28 price target and a Neutral rating. HCP has risen by 16% over the past three months, along with other large-cap REITs, but it is down 17.5% over the past year, compared with a 14% gain in the 12% decline in the S&P U.S. Healthcare REIT Index. We believe that most of the stock’s relative weakness reflects concern about interest rates, deteriorating fundamentals in senior housing and HCP’s restructuring. With HCP’s restructuring nearly at an end, we expect investors to begin valuing the company more on its fundamentals, which we expect to improve, and to worry less about interest rates. Although we think senior housing could remain slow for awhile, we are enthusiastic about HCP’s strategy to leverage its position in life science and MOB." (8/7/2018) Has HCP been receiving favorable news coverage? News articles about HCP stock have trended positive on Monday, according to InfoTrie. The research firm identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. HCP earned a coverage optimism score of 2.3 on InfoTrie's scale. They also assigned headlines about the real estate investment trust a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the company's share price in the near future. Who are some of HCP's key competitors? Some companies that are related to HCP include CROWN CASTLE IN/SH SH (CCI), Prologis (PLD), Public Storage (PSA), Equinix (EQIX), Welltower (WELL), AvalonBay Communities (AVB), Equity Residential (EQR), DIGITAL RLTY TR/SH (DLR), Ventas (VTR), SBA Communications (SBAC), Realty Income (O), Boston Properties (BXP), Weyerhaeuser (WY), Essex Property Trust (ESS) and Alexandria Real Estate Equities (ARE). Who are HCP's key executives? HCP's management team includes the folowing people: Mr. Thomas M. Herzog, Pres, CEO & Director (Age 56)Mr. Peter A. Scott, Exec. VP & CFO (Age 39)Mr. Thomas M. Klaritch, Exec. VP & COO (Age 61)Mr. Troy E. McHenry, Exec. VP, Gen. Counsel & Corp. Sec. (Age 46)Mr. Scott M. Brinker, Exec. VP & Chief Investment Officer (Age 42) Who are HCP's major shareholders? HCP's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (9.71%), Cohen & Steers Inc. (4.82%), Zimmer Partners LP (1.74%), Daiwa Securities Group Inc. (1.68%), Northern Trust Corp (1.65%) and Geode Capital Management LLC (1.63%). Company insiders that own HCP stock include Kendall K Young, R Kent Griffin Jr, Scott A Anderson and Thomas Klaritch. View Institutional Ownership Trends for HCP. Which major investors are selling HCP stock? HCP stock was sold by a variety of institutional investors in the last quarter, including Lasalle Investment Management Securities LLC, Daiwa Securities Group Inc., Becker Capital Management Inc., Bank of New York Mellon Corp, Real Estate Management Services LLC, Prudential Financial Inc., Timbercreek Investment Management Inc. and Westpac Banking Corp. View Insider Buying and Selling for HCP. Which major investors are buying HCP stock? HCP stock was purchased by a variety of institutional investors in the last quarter, including Zimmer Partners LP, Cohen & Steers Inc., BlackRock Inc., Oregon Public Employees Retirement Fund, Geode Capital Management LLC, California Public Employees Retirement System, D. E. Shaw & Co. Inc. and Weiss Multi Strategy Advisers LLC. Company insiders that have bought HCP stock in the last two years include Kendall K Young and R Kent Griffin Jr. View Insider Buying and Selling for HCP. How do I buy shares of HCP? Shares of HCP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is HCP's stock price today? One share of HCP stock can currently be purchased for approximately $30.84. How big of a company is HCP? HCP has a market capitalization of $14.66 billion and generates $1.85 billion in revenue each year. The real estate investment trust earns $414.16 million in net income (profit) each year or $1.82 on an earnings per share basis. HCP employs 190 workers across the globe. What is HCP's official website? The official website for HCP is http://www.hcpi.com. How can I contact HCP? HCP's mailing address is 1920 MAIN STREET SUITE 1200, IRVINE CA, 92614. The real estate investment trust can be reached via phone at 949-407-0700 or via email at [email protected] MarketBeat Community Rating for HCP (NYSE HCP)Community Ranking: 1.7 out of 5 ()Outperform Votes: 345 (Vote Outperform)Underperform Votes: 690 (Vote Underperform)Total Votes: 1,035MarketBeat's community ratings are surveys of what our community members think about HCP and other stocks. Vote "Outperform" if you believe HCP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HCP will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/18/2019 by MarketBeat.com StaffFeatured Article: What are defining characteristics of a correction?